KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
Kumquat Biosciences Inc.
Kumquat Biosciences Inc.
Incyte Corporation
Zhejiang Doer Biologics Co., Ltd.
Pfizer
Turning Point Therapeutics, Inc.
Genentech, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
Erasca, Inc.
Chinese University of Hong Kong
Fudan University
Eisai Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Institute of Oncology Ljubljana
St. Jude Children's Research Hospital
Sichuan Baili Pharmaceutical Co., Ltd.
RenJi Hospital
Shanghai Juncell Therapeutics
Hospices Civils de Lyon
University Hospital, Lille
DualityBio Inc.
Elevation Oncology
Sun Yat-sen University
Sichuan Baili Pharmaceutical Co., Ltd.
Shanghai Zhongshan Hospital
Pfizer
Fujian Cancer Hospital
Peking University
Ruijin Hospital
Hoffmann-La Roche
Sichuan Baili Pharmaceutical Co., Ltd.
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
National Cancer Center Hospital East
Medstar Health Research Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Pfizer
Huashan Hospital
Sichuan Baili Pharmaceutical Co., Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Magentiq Eye LTD
Imunon
Peking University Cancer Hospital & Institute
University of Aarhus
Sichuan Cancer Hospital and Research Institute
NanOlogy, LLC
Theseus Pharmaceuticals
University Medical Center Groningen
Kyowa Kirin Co., Ltd.